Compounds > uric acid
Page last updated: 2024-10-20

uric acid and Auricular Fibrillation

uric acid has been researched along with Auricular Fibrillation in 90 studies

Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.

Research Excerpts

ExcerptRelevanceReference
" This study was to explore whether catheter ablation for atrial fibrillation (AF) patients affects uric acid (UA), glucose and lipid metabolism."9.51Declines in serum uric acid level after catheter ablation of atrial fibrillation. ( Aiki, T; Aoyama, D; Eguchi, T; Fukuoka, Y; Hasegawa, K; Ishida, K; Kakehashi, S; Kataoka, T; Mukai, M; Nagao, M; Sekihara, T; Shiomi, Y; Tada, H; Tama, N; Tsuji, T; Uzui, H; Yamaguchi, J, 2022)
"Increased serum uric acid is associated with prevalence and incidence of atrial fibrillation (AF), but there is a lack of studies on the association between serum uric acid and risk of AF in the general population."9.27Uric Acid and Risk of Atrial Fibrillation in the Korean General Population. ( Kwon, CH; Lee, JY; Lee, SH; Ryu, S; Sung, KC, 2018)
"The independent role of uric acid (UA) as a risk factor for atrial fibrillation (AF) has not been fully elucidated."9.27Uric Acid Level and New-Onset Atrial Fibrillation in the Japanese General Population　- Longitudinal Study. ( Kawasoe, S; Kubozono, T; Maenohara, S; Miyahara, H; Miyata, M; Ohishi, M; Ojima, S; Yoshifuku, S, 2018)
"The association between serum uric acid (UA) levels and atrial fibrillation (AF) in the general population in Japan is not well known."9.22Uric Acid Level and Prevalence of Atrial Fibrillation in a Japanese General Population of 285,882. ( Kawasoe, S; Kubozono, T; Maenohara, S; Miyahara, H; Miyata, M; Ohishi, M; Ojima, S; Oketani, N; Yoshifuku, S, 2016)
"Increasing evidence supports the hypothesis that high serum uric acid (SUA) levels are related to atrial fibrillation (AF)."9.12Relationship between serum uric acid levels and different types of atrial fibrillation: An updated meta-analysis. ( Hou, Y; Li, H; Li, Z; Ren, M; Shang, L; Wang, X; Zhang, Y; Zhou, J, 2021)
"Several studies were published to assess the association between serum uric acid levels and atrial fibrillation risk, but no consistent results were reported."8.93Association Between Serum Uric Acid Levels and Atrial Fibrillation Risk. ( Huang, DS; Ma, YJ; Shen, D; Sun, HY; Wang, YM; Zhang, CH; Zhang, LW, 2016)
"Studies showed that elevated preoperative serum uric acid(SUA) levels are associated with recurrence of atrial fibrillation(AF) after catheter ablation."8.31Serum uric acid: creatinine ratio (UCR) is associated with recurrence of atrial fibrillation after catheter ablation. ( Hou, Y; Li, Z; Shang, L; Wang, Y; Yang, X; Zhang, Y, 2023)
"Background The role of uric acid is gaining increasing importance in the evaluation of cardiovascular disease, but its relationship with atrial fibrillation (AF) is unclear."8.31Elevated Uric Acid Is Associated With New-Onset Atrial Fibrillation: Results From the Swedish AMORIS Cohort. ( Ding, M; Gigante, B; Hammar, N; Lind, V; Modig, K; Viet, NN, 2023)
"Previous studies have shown both dysglycaemia and hyperuricemia are associated with an increased risk of atrial fibrillation (AF), while the relationship between serum uric acid (SUA) levels and AF in different fasting glucose patterns (FBG) is unclear."8.31Association between serum uric acid levels and atrial fibrillation in different fasting glucose patterns: A case-control study. ( Jiao, H; Teng, J; Yang, M; Zhao, D; Zhong, X, 2023)
"BACKGROUND Although serum uric acid (SUA) levels have been reported to be associated with atrial fibrillation (AF), the specific associations remain unclear."8.12Serum Uric Acid Levels in Relation to Atrial Fibrillation: A Case-Control Study. ( Jiao, H; Teng, J; Zhao, D; Zhong, X, 2022)
"BACKGROUND The association between patients' serum uric acid (SUA) levels and sex in atrial fibrillation (AF) remains controversial."8.12Retrospective Study from a Single Center to Evaluate the Association Between Sex and Serum Uric Acid Levels in 950 Patients with Atrial Fibrillation. ( Jiao, H; Teng, J; Zhao, D; Zhong, X, 2022)
"The relationship between serum uric acid (SUA) levels and paroxysmal atrial fibrillation (AF) remains controversial."8.12A case-control study to investigate association between serum uric acid levels and paroxysmal atrial fibrillation. ( Jiao, H; Teng, J; Zhao, D; Zhong, X, 2022)
"There is a lack of studies supporting the association between the uric acid/albumin ratio (UAR) and the development of new-onset atrial fibrillation (NOAF) in ST-elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (pPCI)."8.12Predictive value of uric acid/albumin ratio for the prediction of new-onset atrial fibrillation in patients with ST-Elevation myocardial infarction. ( Akbulut, T; Asal, S; Çiçek, V; Çınar, T; Hayıroğlu, Mİ; Şaylık, F; Selçuk, M; Tanboğa, İH, 2022)
"Observational studies have shown that high levels of serum uric acid (UA) were associated with atrial fibrillation (AF)."7.96A mendelian randomization analysis: The causal association between serum uric acid and atrial fibrillation. ( Hong, M; Hwang, I; Jee, SH; Joung, B; Kim, TH; Lee, MH; Pak, HN; Park, JW; Uhm, JS; Yang, PS; Yu, HT, 2020)
"To investigate the effects of gender on the association of serum uric acid (SUA) levels and atrial fibrillation (AF) prevalence in a community-based Chinese population."7.85Association between serum uric acid and atrial fibrillation: a cross-sectional community-based study in China. ( Chen, Y; Han, X; Liu, H; Liu, Y; Qiu, J; Xia, Y; Yang, Y; Yin, X; Zhou, Y, 2017)
"We aimed to examine the relationship between serum uric acid levels and left atrial appendage (LAA) peak flow velocity, an indicator of the mechanical functions of the LAA, and atrial fibrillation (AF)."7.81Increased serum uric acid levels are correlated with decreased left atrial appendage peak flow velocity in patients with atrial fibrillation. ( Barcin, C; Bugan, B; Celik, M; Gokoglan, Y; Kabul, HK; Yalcinkaya, E; Yuksel, UC, 2015)
"To investigate the association between serum uric acid levels and the risk of incident atrial fibrillation in patients after coronary artery bypass graft (cABG) operation."7.81Serum uric acid level predicts new-onset atrial fibrillation after coronary artery bypass graft operation. ( Arslan, Y; Çoskun, G; Demirtas, M; Günay, R; Güney, MR; Kehlibar, T; Ketenci, B; Kocaaslan, C; Memetoglu, ME; Tuygun, A; Yılmaz, M, 2015)
"The objective of this observational study was to determine whether there is an association between atrial fibrillation (AF) and uric acid and to identify the risk markers for AF in obstructive sleep apnea (OSA)."7.80Uric acid levels in obstructive sleep apnea patients with atrial fibrillation. ( Chen, JH; He, YQ; Niu, HY; Wan, YF; Wang, Y; Xu, CQ; Zheng, DH; Zheng, YL, 2014)
"Serum uric acid (SUA) has been associated with cardiovascular disease in population studies, but its relation to atrial fibrillation (AF) is largely unknown."7.80Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women--the Tromso Study. ( Hansen, JB; Løchen, ML; Mathiesen, EB; Njølstad, I; Nyrnes, A; Toft, I; Wilsgaard, T, 2014)
"We evaluated the association between serum uric acid (SUA) and atrial fibrillation (AF) in patients with chronic heart failure (HF)."7.79Serum uric acid levels are associated with atrial fibrillation in patients with ischemic heart failure. ( Erbay, AR; Tekin, G; Tekin, YK; Turhan, H; Yetkin, E, 2013)
"The association between serum uric acid (SUA) levels and atrial fibrillation (AF) is currently poorly known."7.79Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus. ( Arcaro, G; Bertolini, L; Bonapace, S; Byrne, CD; Targher, G; Valbusa, F; Zenari, L; Zoppini, G, 2013)
"Recently there has been a great deal of interest in the role of serum uric acid (SUA) in atrial fibrillation (AF)."7.79Serum uric acid levels correlate with recurrence of paroxysmal atrial fibrillation after catheter ablation. ( Dong, JZ; He, XN; Li, SN; Long, DY; Ma, CS; Tang, RB; Xie, SL; Yu, RH; Zhan, JL; Zhang, ZJ, 2013)
"Studies have shown that increased levels of serum uric acid (SUA) are associated with atrial fibrillation (AF)."7.78Serum uric acid levels correlate with atrial fibrillation in patients with chronic systolic heart failure. ( Cui, HY; Huang, CX; Huang, H; Huang, T; Qin, M; Yu, SB; Zhao, QY, 2012)
"Although various kinds of cardiovascular risk factors have been reported to be associated with atrial fibrillation (AF), the relationship between serum uric acid level and AF has not been fully examined."7.78Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence. ( Aizawa, T; Funada, R; Kirigaya, H; Koike, A; Matsuno, S; Nagashima, K; Oikawa, Y; Otsuka, T; Sagara, K; Sawada, H; Suzuki, S; Uejima, T; Yajima, J; Yamashita, T, 2012)
"Fibrosis is the culprit in the electrical derangement of the myocytes."5.91Uric acid significantly correlates with the presence of low-voltage areas at the endocardial mapping in patients with non-valvular atrial fibrillation. ( Baroni, M; Carbonaro, M; Ciampi, CM; Fortuna, M; Giannattasio, C; Gigli, L; Leidi, F; Maloberti, A; Mazzone, P; Paolucci, M; Testoni, A; Vargiu, S; Varrenti, M, 2023)
"The primary outcome was the late recurrence after treatment."5.72Association of Uric Acid Albumin Ratio with Recurrence of Atrial Fibrillation after Cryoballoon Catheter Ablation. ( Çam, N; Çınar, T; Durmuş, G; Gökalp, M; Gürkan, K; Hayıroğlu, Mİ; Karataş, MB; Zengin, A, 2022)
" This study was to explore whether catheter ablation for atrial fibrillation (AF) patients affects uric acid (UA), glucose and lipid metabolism."5.51Declines in serum uric acid level after catheter ablation of atrial fibrillation. ( Aiki, T; Aoyama, D; Eguchi, T; Fukuoka, Y; Hasegawa, K; Ishida, K; Kakehashi, S; Kataoka, T; Mukai, M; Nagao, M; Sekihara, T; Shiomi, Y; Tada, H; Tama, N; Tsuji, T; Uzui, H; Yamaguchi, J, 2022)
"SUA levels in patients with LA thrombus were significantly greater (413."5.40Serum uric acid and risk of left atrial thrombus in patients with nonvalvular atrial fibrillation. ( Bai, R; Dong, JZ; Du, X; Jiang, CX; Kang, JP; Long, DY; Ma, CS; Ning, M; Salim, M; Sang, CH; Tang, RB; Wu, JH; Yan, XL; Yao, Y; Yu, RH, 2014)
"Atrial fibrillation recurrence rates from the lowest to the highest SUA quartiles were 2."5.40Usefulness of serum uric acid level to predict atrial fibrillation recurrence after cryoballoon-based catheter ablation. ( Aras, D; Aytemir, K; Canpolat, U; Çay, S; Kaya, EB; Oto, A; Şahiner, L; Topaloğlu, S; Yorgun, H, 2014)
"Uric acid (UA) is a cardiovascular risk marker associated with oxidative stress and inflammation."5.37Uric acid levels and atrial fibrillation in hypertensive patients. ( Korantzopoulos, P; Li, G; Liu, T; Wang, S; Zhang, X, 2011)
"The independent role of uric acid (UA) as a risk factor for atrial fibrillation (AF) has not been fully elucidated."5.27Uric Acid Level and New-Onset Atrial Fibrillation in the Japanese General Population　- Longitudinal Study. ( Kawasoe, S; Kubozono, T; Maenohara, S; Miyahara, H; Miyata, M; Ohishi, M; Ojima, S; Yoshifuku, S, 2018)
"Increased serum uric acid is associated with prevalence and incidence of atrial fibrillation (AF), but there is a lack of studies on the association between serum uric acid and risk of AF in the general population."5.27Uric Acid and Risk of Atrial Fibrillation in the Korean General Population. ( Kwon, CH; Lee, JY; Lee, SH; Ryu, S; Sung, KC, 2018)
"The association between serum uric acid (UA) levels and atrial fibrillation (AF) in the general population in Japan is not well known."5.22Uric Acid Level and Prevalence of Atrial Fibrillation in a Japanese General Population of 285,882. ( Kawasoe, S; Kubozono, T; Maenohara, S; Miyahara, H; Miyata, M; Ohishi, M; Ojima, S; Oketani, N; Yoshifuku, S, 2016)
" Although hyperuricemia is a risk factor for cardiovascular diseases, the relationship between serum uric acid (UA) levels and thromboembolic risk has not been fully elucidated in patients with AF."5.19Hyperuricemia and transesophageal echocardiographic thromboembolic risk in patients with atrial fibrillation at clinically low-intermediate risk. ( Fukuda, N; Hirai, T; Inoue, H; Nakagawa, K; Nozawa, T; Numa, S; Ohara, K, 2014)
"Although hyperuricemia was associated with several cardiovascular diseases, the role of uric acid (UA) in left atrial (LA) remodeling and new-onset atrial fibrillation (AF) has not been fully explored."5.17The association between hyperuricemia, left atrial size and new-onset atrial fibrillation. ( Chang, SL; Chao, TF; Chen, SA; Chen, SJ; Chen, TJ; Hu, YF; Hung, CL; Lin, YJ; Lo, LW; Tuan, TC; Wang, KL, 2013)
"Increasing evidence supports the hypothesis that high serum uric acid (SUA) levels are related to atrial fibrillation (AF)."5.12Relationship between serum uric acid levels and different types of atrial fibrillation: An updated meta-analysis. ( Hou, Y; Li, H; Li, Z; Ren, M; Shang, L; Wang, X; Zhang, Y; Zhou, J, 2021)
"Several studies were published to assess the association between serum uric acid levels and atrial fibrillation risk, but no consistent results were reported."4.93Association Between Serum Uric Acid Levels and Atrial Fibrillation Risk. ( Huang, DS; Ma, YJ; Shen, D; Sun, HY; Wang, YM; Zhang, CH; Zhang, LW, 2016)
"Studies showed that elevated preoperative serum uric acid(SUA) levels are associated with recurrence of atrial fibrillation(AF) after catheter ablation."4.31Serum uric acid: creatinine ratio (UCR) is associated with recurrence of atrial fibrillation after catheter ablation. ( Hou, Y; Li, Z; Shang, L; Wang, Y; Yang, X; Zhang, Y, 2023)
"In the present study, we investigated the association between risk factors for atherosclerosis [including HU, HTN, blood pressure and serum uric acid (UA) levels] and paroxysmal atrial fibrillation (Paro-AF) or persistent atrial fibrillation (Pers-AF) in patients who underwent coronary computed tomography angiography (CCTA)."4.31Association between paroxysmal or persistent atrial fibrillation and hyperuricemia in patients who underwent coronary computed tomography angiography: from the FU-CCTA-AF Registry. ( Higashi, S; Ideishi, A; Kawahira, Y; Komaki, T; Mikagi, M; Miura, SI; Ogawa, M; Shiga, Y; Suematsu, Y; Tachibana, T; Tashiro, K, 2023)
"Background The role of uric acid is gaining increasing importance in the evaluation of cardiovascular disease, but its relationship with atrial fibrillation (AF) is unclear."4.31Elevated Uric Acid Is Associated With New-Onset Atrial Fibrillation: Results From the Swedish AMORIS Cohort. ( Ding, M; Gigante, B; Hammar, N; Lind, V; Modig, K; Viet, NN, 2023)
" There were statistically significant differences between the two groups in terms of age, body mass index (BMI), N-terminal prohormone of brain natriuretic peptide NT-probNP, fibrinogen, CHA2DS2-VASC [congestive Heart Failure, Hypertension, Age (75 or older), diabetes mellitus, stroke, vascular disease, age (65-74), sex category] score, paroxysmal atrial fibrillation, renal insufficiency, D-dimer, heart failure, and serum uric acid (p<0."4.31Predictive value of echocardiography combined with CT angiography for left atrial appendage thrombosis in patients with non-valvular atrial fibrillation. ( Xing, LM; Zhong, J, 2023)
"Previous studies have shown both dysglycaemia and hyperuricemia are associated with an increased risk of atrial fibrillation (AF), while the relationship between serum uric acid (SUA) levels and AF in different fasting glucose patterns (FBG) is unclear."4.31Association between serum uric acid levels and atrial fibrillation in different fasting glucose patterns: A case-control study. ( Jiao, H; Teng, J; Yang, M; Zhao, D; Zhong, X, 2023)
"BACKGROUND The association between patients' serum uric acid (SUA) levels and sex in atrial fibrillation (AF) remains controversial."4.12Retrospective Study from a Single Center to Evaluate the Association Between Sex and Serum Uric Acid Levels in 950 Patients with Atrial Fibrillation. ( Jiao, H; Teng, J; Zhao, D; Zhong, X, 2022)
"There is a lack of studies supporting the association between the uric acid/albumin ratio (UAR) and the development of new-onset atrial fibrillation (NOAF) in ST-elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (pPCI)."4.12Predictive value of uric acid/albumin ratio for the prediction of new-onset atrial fibrillation in patients with ST-Elevation myocardial infarction. ( Akbulut, T; Asal, S; Çiçek, V; Çınar, T; Hayıroğlu, Mİ; Şaylık, F; Selçuk, M; Tanboğa, İH, 2022)
"BACKGROUND Although serum uric acid (SUA) levels have been reported to be associated with atrial fibrillation (AF), the specific associations remain unclear."4.12Serum Uric Acid Levels in Relation to Atrial Fibrillation: A Case-Control Study. ( Jiao, H; Teng, J; Zhao, D; Zhong, X, 2022)
"The relationship between serum uric acid (SUA) levels and paroxysmal atrial fibrillation (AF) remains controversial."4.12A case-control study to investigate association between serum uric acid levels and paroxysmal atrial fibrillation. ( Jiao, H; Teng, J; Zhao, D; Zhong, X, 2022)
"High levels of serum uric acid is closely associated with atrial fibrillation (AF); nonetheless, the detailed mechanisms remain unknown."4.02Increased Susceptibility of Atrial Fibrillation Induced by Hyperuricemia in Rats: Mechanisms and Implications. ( Li, Y; Liang, D; Liang, Z; Liu, H; Liu, Y; Su, M; Sun, L; Wang, D; Wei, Y; Yin, S; Zhang, G; Zhang, S; Zhao, J, 2021)
" The AHEAD (A: atrial fibrillation; H: hemoglobin; E: elderly; A: abnormal renal parameters; D: diabetes mellitus) and AHEAD-U (A: atrial fibrillation; H: hemoglobin; E: elderly; A: abnormal renal parameters; D: diabetes mellitus, U: uric acid) are popular prognostic scoring systems."3.96A statistical predictive model consistent within a 5-year follow-up period for patients with acute heart failure. ( Chan, CH; Cheng, HM; Chou, YC; Guo, CY; Sung, SH, 2020)
"Observational studies have shown that high levels of serum uric acid (UA) were associated with atrial fibrillation (AF)."3.96A mendelian randomization analysis: The causal association between serum uric acid and atrial fibrillation. ( Hong, M; Hwang, I; Jee, SH; Joung, B; Kim, TH; Lee, MH; Pak, HN; Park, JW; Uhm, JS; Yang, PS; Yu, HT, 2020)
" Hyperuricemia was defined as a serum uric acid level >7 mg/dl for men and >6 mg/dl for women or allopurinol use."3.88Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring. ( Bolzan, B; Bonapace, S; Bonora, E; Civettini, A; Dugo, C; Mantovani, A; Morani, G; Rigolon, R; Targher, G; Zoppini, G, 2018)
"To investigate the effects of gender on the association of serum uric acid (SUA) levels and atrial fibrillation (AF) prevalence in a community-based Chinese population."3.85Association between serum uric acid and atrial fibrillation: a cross-sectional community-based study in China. ( Chen, Y; Han, X; Liu, H; Liu, Y; Qiu, J; Xia, Y; Yang, Y; Yin, X; Zhou, Y, 2017)
"The relationship between serum uric acid (SUA) and atrial fibrillation (AF) remains unclear because many parameters and diseases influence AF."3.85Hyperuricemia is an independent competing risk factor for atrial fibrillation. ( Hisatome, I; Kario, K; Kuwabara, M; Nishi, Y; Nishihara, S; Niwa, K; Takahashi, O; Yamamoto, K; Yamashita, T, 2017)
" After adjustment of age, gender, education level, income, drink, history of myocardial infarction, history of stroke, serum uric acid and C reactive protein level, multiple Cox regression analysis showed that one health score point increase was related to 8% reduction of new onset atrial fibrillation(HR=0."3.83[Association between the cardiovascular health score and new-onset atrial fibrillation]. ( Ji, CP; Shi, JH; Wang, YZ; Wei, XM; Wu, SL; Xing, AJ; Zhu, CR, 2016)
" Hyperuricemia was defined as a serum uric acid level >7 mg/dl for men and >6 mg/dl for women or allopurinol use."3.83Hyperuricemia is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. ( Bergamini, C; Bonora, E; Mantovani, A; Pernigo, M; Pichiri, I; Rigolon, R; Targher, G; Zoppini, G, 2016)
"We aimed to examine the relationship between serum uric acid levels and left atrial appendage (LAA) peak flow velocity, an indicator of the mechanical functions of the LAA, and atrial fibrillation (AF)."3.81Increased serum uric acid levels are correlated with decreased left atrial appendage peak flow velocity in patients with atrial fibrillation. ( Barcin, C; Bugan, B; Celik, M; Gokoglan, Y; Kabul, HK; Yalcinkaya, E; Yuksel, UC, 2015)
"To investigate the association between serum uric acid levels and the risk of incident atrial fibrillation in patients after coronary artery bypass graft (cABG) operation."3.81Serum uric acid level predicts new-onset atrial fibrillation after coronary artery bypass graft operation. ( Arslan, Y; Çoskun, G; Demirtas, M; Günay, R; Güney, MR; Kehlibar, T; Ketenci, B; Kocaaslan, C; Memetoglu, ME; Tuygun, A; Yılmaz, M, 2015)
"Serum uric acid (SUA) has been associated with cardiovascular disease in population studies, but its relation to atrial fibrillation (AF) is largely unknown."3.80Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women--the Tromso Study. ( Hansen, JB; Løchen, ML; Mathiesen, EB; Njølstad, I; Nyrnes, A; Toft, I; Wilsgaard, T, 2014)
"The objective of this observational study was to determine whether there is an association between atrial fibrillation (AF) and uric acid and to identify the risk markers for AF in obstructive sleep apnea (OSA)."3.80Uric acid levels in obstructive sleep apnea patients with atrial fibrillation. ( Chen, JH; He, YQ; Niu, HY; Wan, YF; Wang, Y; Xu, CQ; Zheng, DH; Zheng, YL, 2014)
" Hyperuricemia was defined as levels of uric acid >7."3.80Hyperuricemia and incident atrial fibrillation in a normotensive elderly population in Taiwan. ( Chia-Yu Chen, R; Chuang, SY; Hsu, PF; Hsu, YY; Liu, WL; Pan, WH; Wu, CC, 2014)
"Recently there has been a great deal of interest in the role of serum uric acid (SUA) in atrial fibrillation (AF)."3.79Serum uric acid levels correlate with recurrence of paroxysmal atrial fibrillation after catheter ablation. ( Dong, JZ; He, XN; Li, SN; Long, DY; Ma, CS; Tang, RB; Xie, SL; Yu, RH; Zhan, JL; Zhang, ZJ, 2013)
"The association between serum uric acid (SUA) levels and atrial fibrillation (AF) is currently poorly known."3.79Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus. ( Arcaro, G; Bertolini, L; Bonapace, S; Byrne, CD; Targher, G; Valbusa, F; Zenari, L; Zoppini, G, 2013)
"We evaluated the association between serum uric acid (SUA) and atrial fibrillation (AF) in patients with chronic heart failure (HF)."3.79Serum uric acid levels are associated with atrial fibrillation in patients with ischemic heart failure. ( Erbay, AR; Tekin, G; Tekin, YK; Turhan, H; Yetkin, E, 2013)
"Although various kinds of cardiovascular risk factors have been reported to be associated with atrial fibrillation (AF), the relationship between serum uric acid level and AF has not been fully examined."3.78Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence. ( Aizawa, T; Funada, R; Kirigaya, H; Koike, A; Matsuno, S; Nagashima, K; Oikawa, Y; Otsuka, T; Sagara, K; Sawada, H; Suzuki, S; Uejima, T; Yajima, J; Yamashita, T, 2012)
"Studies have shown that increased levels of serum uric acid (SUA) are associated with atrial fibrillation (AF)."3.78Serum uric acid levels correlate with atrial fibrillation in patients with chronic systolic heart failure. ( Cui, HY; Huang, CX; Huang, H; Huang, T; Qin, M; Yu, SB; Zhao, QY, 2012)
"Hyperuricemia has been widely accepted to be associated with the incidence of paroxysmal or persistent AF, as well as to the risk of AF in post cardiovascular surgery patients."2.53Hyperuricemia and Atrial Fibrillation. ( Hisatome, I; Kuwabara, M; Maharani, N, 2016)
"Fibrosis is the culprit in the electrical derangement of the myocytes."1.91Uric acid significantly correlates with the presence of low-voltage areas at the endocardial mapping in patients with non-valvular atrial fibrillation. ( Baroni, M; Carbonaro, M; Ciampi, CM; Fortuna, M; Giannattasio, C; Gigli, L; Leidi, F; Maloberti, A; Mazzone, P; Paolucci, M; Testoni, A; Vargiu, S; Varrenti, M, 2023)
"The primary outcome was the late recurrence after treatment."1.72Association of Uric Acid Albumin Ratio with Recurrence of Atrial Fibrillation after Cryoballoon Catheter Ablation. ( Çam, N; Çınar, T; Durmuş, G; Gökalp, M; Gürkan, K; Hayıroğlu, Mİ; Karataş, MB; Zengin, A, 2022)
"Hyperuricemia is associated with the risk of developing atrial fibrillation (AF) and heart failure."1.72Association of Hyperuricemia with Impaired Left Ventricular Systolic Function in Patients with Atrial Fibrillation and Preserved Kidney Function: Analysis of the POL-AF Registry Cohort. ( Bakuła-Ostalska, E; Bednarski, J; Bil, J; Błaszczyk, R; Gawałko, M; Gorczyca-Głowacka, I; Jelonek, O; Kapłon-Cieślicka, A; Krzciuk, M; Lubas, A; Maciorowska, M; Mamcarz, A; Rajtar-Salwa, R; Szpotowicz, A; Szyszkowska, A; Tokarek, T; Tomaszuk-Kazberuk, A; Uziębło-Życzkowska, B; Wełnicki, M; Wójcik, M; Wójcik, W; Wojewódzki, M; Wożakowska-Kapłon, B, 2022)
"Hyperuricemia is a risk factor for cardiovascular diseases."1.48Hyperuricemia is associated with atrial fibrillation prevalence in very elderly - a community based study in Chengdu, China. ( Huang, G; Liu, Y; Liu, ZH; Xie, X; Xu, JB; Xu, RH; Zhang, TJ, 2018)
"Atrial fibrillation and nonalcoholic fatty liver disease are two pathological conditions that are highly prevalent worldwide and share multiple CVD risk factors."1.48Nonalcoholic Fatty Liver Disease Is Associated with Increased Atrial Fibrillation Risk in an Elderly Chinese Population: A Cross-Sectional Study. ( Li, P; Liu, Y; Miao, M; Pan, Y; Xu, C; Xu, L; Zhang, Y; Zhu, Z, 2018)
"SUA levels in patients with LA thrombus were significantly greater (413."1.40Serum uric acid and risk of left atrial thrombus in patients with nonvalvular atrial fibrillation. ( Bai, R; Dong, JZ; Du, X; Jiang, CX; Kang, JP; Long, DY; Ma, CS; Ning, M; Salim, M; Sang, CH; Tang, RB; Wu, JH; Yan, XL; Yao, Y; Yu, RH, 2014)
"Atrial fibrillation recurrence rates from the lowest to the highest SUA quartiles were 2."1.40Usefulness of serum uric acid level to predict atrial fibrillation recurrence after cryoballoon-based catheter ablation. ( Aras, D; Aytemir, K; Canpolat, U; Çay, S; Kaya, EB; Oto, A; Şahiner, L; Topaloğlu, S; Yorgun, H, 2014)
"Uric acid (UA) is a cardiovascular risk marker associated with oxidative stress and inflammation."1.37Uric acid levels and atrial fibrillation in hypertensive patients. ( Korantzopoulos, P; Li, G; Liu, T; Wang, S; Zhang, X, 2011)

Research

Studies (90)

TimeframeStudies, this research(%)All Research%
pre-19904 (4.44)18.7374
1990's1 (1.11)18.2507
2000's1 (1.11)29.6817
2010's57 (63.33)24.3611
2020's27 (30.00)2.80

Authors

AuthorsStudies
Feng, X2
Wu, F1
Wu, Y3
Ding, S1
Tao, X1
Li, J9
Liu, W1
Ma, R1
Chen, Y5
Wang, S5
Wei, Y5
Hidru, TH1
Li, D3
Wang, N1
Yang, Y4
Wang, Y5
Yang, X5
Xia, Y4
Tang, L1
Fang, L1
Zhong, X4
Jiao, H4
Zhao, D4
Teng, J4
Zhang, Q3
Huang, S1
Tang, J1
Chang, Q1
Wełnicki, M1
Gorczyca-Głowacka, I1
Lubas, A1
Wójcik, W1
Jelonek, O1
Maciorowska, M1
Uziębło-Życzkowska, B1
Wójcik, M1
Błaszczyk, R1
Rajtar-Salwa, R1
Tokarek, T1
Bil, J1
Wojewódzki, M1
Szpotowicz, A1
Krzciuk, M1
Gawałko, M1
Kapłon-Cieślicka, A1
Tomaszuk-Kazberuk, A1
Szyszkowska, A1
Bednarski, J1
Bakuła-Ostalska, E1
Wożakowska-Kapłon, B1
Mamcarz, A1
Aoyama, D1
Uzui, H1
Sekihara, T1
Eguchi, T1
Hasegawa, K1
Tsuji, T1
Kataoka, T1
Nagao, M1
Kakehashi, S1
Mukai, M1
Aiki, T1
Yamaguchi, J1
Shiomi, Y1
Tama, N1
Fukuoka, Y1
Ishida, K1
Tada, H1
Selçuk, M1
Çınar, T2
Şaylık, F1
Akbulut, T1
Asal, S1
Çiçek, V1
Hayıroğlu, Mİ2
Tanboğa, İH1
Karataş, MB2
Durmuş, G2
Zengin, A1
Gökalp, M1
Gürkan, K1
Çam, N1
Ding, M1
Viet, NN1
Gigante, B1
Lind, V1
Hammar, N1
Modig, K1
Yang, M1
Baroni, M1
Fortuna, M1
Maloberti, A1
Leidi, F1
Ciampi, CM1
Carbonaro, M1
Testoni, A1
Vargiu, S1
Varrenti, M1
Paolucci, M1
Gigli, L1
Giannattasio, C1
Mazzone, P1
Zhang, Y9
Li, Z4
Shang, L2
Hou, Y5
Mikagi, M1
Tashiro, K1
Komaki, T1
Shiga, Y1
Tachibana, T1
Higashi, S1
Kawahira, Y1
Suematsu, Y1
Ideishi, A1
Ogawa, M1
Miura, SI1
Wu, X2
Xu, Z2
Feng, Y1
Zhong, J1
Xing, LM1
Kobayashi, Y1
Omote, K1
Nagai, T1
Kamiya, K1
Konishi, T1
Sato, T1
Kato, Y1
Komoriyama, H1
Tsujinaga, S1
Iwano, H1
Yamamoto, K2
Yoshikawa, T1
Saito, Y1
Anzai, T1
Hong, M2
Park, JW1
Yang, PS1
Hwang, I1
Kim, TH1
Yu, HT1
Uhm, JS1
Joung, B1
Lee, MH1
Jee, SH1
Pak, HN1
Guo, CY2
Chan, CH1
Chou, YC1
Sung, SH2
Cheng, HM2
Nguépy Keubo, FR1
Mboua, PC1
Djifack Tadongfack, T1
Fokouong Tchoffo, E1
Tasson Tatang, C1
Ide Zeuna, J1
Noupoue, EM1
Tsoplifack, CB1
Folefack, GO1
Kettani, M1
Bandelier, P1
Huo, J1
Li, H6
Yu, D1
Arulsamy, N1
AlAbbad, S1
Sardot, T1
Lekashvili, O1
Decato, D1
Lelj, F1
Alexander Ross, JB1
Rosenberg, E1
Nazir, H1
Muthuswamy, N1
Louis, C1
Jose, S1
Prakash, J1
Buan, MEM1
Flox, C1
Chavan, S1
Shi, X1
Kauranen, P1
Kallio, T1
Maia, G1
Tammeveski, K1
Lymperopoulos, N1
Carcadea, E1
Veziroglu, E1
Iranzo, A1
M Kannan, A1
Arunamata, A1
Tacy, TA1
Kache, S1
Mainwaring, RD1
Ma, M1
Maeda, K1
Punn, R1
Noguchi, S1
Hahn, S3
Iwasa, Y3
Ling, J2
Voccio, JP2
Kim, Y3
Song, J3
Bascuñán, J2
Chu, Y1
Tomita, M1
Cazorla, M1
Herrera, E1
Palomeque, E1
Saud, N1
Hoplock, LB1
Lobchuk, MM1
Lemoine, J1
Li, X10
Henson, MA1
Unsihuay, D1
Qiu, J3
Swaroop, S1
Nagornov, KO1
Kozhinov, AN1
Tsybin, YO1
Kuang, S1
Laskin, J1
Zin, NNINM1
Mohamad, MN1
Roslan, K1
Abdul Wafi, S1
Abdul Moin, NI1
Alias, A1
Zakaria, Y1
Abu-Bakar, N1
Naveed, A1
Jilani, K1
Siddique, AB1
Akbar, M1
Riaz, M1
Mushtaq, Z1
Sikandar, M1
Ilyas, S1
Bibi, I1
Asghar, A1
Rasool, G1
Irfan, M1
Li, XY1
Zhao, S1
Fan, XH1
Chen, KP1
Hua, W1
Liu, ZM1
Xue, XD1
Zhou, B1
Zhang, S3
Xing, YL1
Chen, MA1
Sun, Y1
Neradilek, MB1
Wu, XT1
Zhang, D2
Huang, W1
Cui, Y1
Yang, QQ1
Li, HW1
Zhao, XQ1
Hossein Rashidi, B1
Tarafdari, A1
Ghazimirsaeed, ST1
Shahrokh Tehraninezhad, E1
Keikha, F1
Eslami, B1
Ghazimirsaeed, SM1
Jafarabadi, M1
Silvani, Y1
Lovita, AND1
Maharani, A1
Wiyasa, IWA1
Sujuti, H1
Ratnawati, R1
Raras, TYM1
Lemin, AS1
Rahman, MM1
Pangarah, CA1
Kiyu, A1
Zeng, C2
Du, H1
Lin, D1
Jalan, D1
Rubagumya, F1
Hopman, WM1
Vanderpuye, V1
Lopes, G1
Seruga, B1
Booth, CM1
Berry, S1
Hammad, N1
Sajo, EA1
Okunade, KS1
Olorunfemi, G1
Rabiu, KA1
Anorlu, RI1
Xu, C3
Xiang, Y1
Xu, X1
Zhou, L2
Dong, X1
Tang, S1
Gao, XC1
Wei, CH1
Zhang, RG1
Cai, Q1
He, Y1
Tong, F1
Dong, JH1
Wu, G1
Dong, XR1
Tang, X1
Tao, F1
Xiang, W2
Zhao, Y2
Jin, L1
Tao, H1
Lei, Y1
Gan, H1
Huang, Y1
Chen, L3
Shan, A1
Zhao, H2
Wu, M3
Ma, Q1
Wang, J4
Zhang, E2
Zhang, J3
Li, Y6
Xue, F1
Deng, L1
Liu, L2
Yan, Z2
Meng, J1
Chen, G2
Anastassiadou, M1
Bernasconi, G1
Brancato, A1
Carrasco Cabrera, L1
Greco, L1
Jarrah, S1
Kazocina, A1
Leuschner, R1
Magrans, JO1
Miron, I1
Nave, S1
Pedersen, R1
Reich, H1
Rojas, A1
Sacchi, A1
Santos, M1
Theobald, A1
Vagenende, B1
Verani, A1
Du, L1
Liu, X1
Ren, Y1
Li, P2
Jiao, Q1
Meng, P1
Wang, F2
Wang, YS1
Wang, C3
Zhou, X3
Wang, W1
Hou, J1
Zhang, A1
Lv, B1
Gao, C1
Pang, D1
Lu, K1
Ahmad, NH1
Wang, L1
Zhu, J2
Zhang, L2
Zhuang, T1
Tu, J1
Zhao, Z1
Qu, Y1
Yao, H1
Wang, X8
Lee, DF1
Shen, J3
Wen, L1
Huang, G3
Xie, X2
Zhao, Q1
Hu, W1
Lu, J2
Li, M1
Li, W2
Wu, W1
Du, F1
Ji, H1
Wan, L1
Wen, Q1
Cho, CH1
Zou, C1
Xiao, Z1
Liao, J1
Su, X1
Bi, Z1
Su, Q1
Huang, H2
Gao, Y2
Na, KJ1
Choi, H1
Oh, HR1
Kim, YH1
Lee, SB1
Jung, YJ1
Koh, J1
Park, S1
Lee, HJ1
Jeon, YK1
Chung, DH1
Paeng, JC1
Park, IK1
Kang, CH1
Cheon, GJ1
Kang, KW1
Lee, DS1
Kim, YT1
Pajuelo-Lozano, N1
Alcalá, S1
Sainz, B1
Perona, R1
Sanchez-Perez, I1
Logotheti, S1
Marquardt, S1
Gupta, SK1
Richter, C1
Edelhäuser, BAH1
Engelmann, D1
Brenmoehl, J1
Söhnchen, C1
Murr, N1
Alpers, M1
Singh, KP1
Wolkenhauer, O1
Heckl, D1
Spitschak, A1
Pützer, BM1
Liao, Y1
Cheng, J2
Kong, X1
Li, S2
Zhang, M4
Zhang, H1
Yang, T2
Dong, Y1
Xu, Y1
Yuan, Z1
Cao, J1
Zheng, Y1
Luo, Z1
Mei, Z1
Yao, Y2
Liu, Z2
Liang, C1
Yang, H1
Song, Y1
Yu, K1
Zhu, C1
Huang, Z1
Qian, J1
Ge, J1
Hu, J2
Wang, H2
Liu, Y8
Mi, Y1
Kong, H1
Xi, D1
Yan, W1
Luo, X1
Ning, Q1
Chang, X2
Zhang, T2
Wang, Q2
Rathore, MG1
Reddy, K1
Chen, H1
Shin, SH1
Ma, WY1
Bode, AM1
Dong, Z1
Mu, W1
Liu, C3
Gao, F1
Qi, Y1
Lu, H1
Zhang, X5
Cai, X1
Ji, RY1
Tian, J2
Shi, Y1
Ying, S1
Tan, M1
Feng, G1
Kuang, Y1
Chen, D1
Wu, D3
Zhu, ZQ1
Tang, HX1
Shi, ZE1
Kang, J1
Liu, Q1
Qi, J2
Mu, J1
Cong, Z1
Chen, S2
Fu, D1
Celestrin, CP1
Rocha, GZ1
Stein, AM1
Guadagnini, D1
Tadelle, RM1
Saad, MJA1
Oliveira, AG1
Bianconi, V1
Bronzo, P1
Banach, M1
Sahebkar, A1
Mannarino, MR1
Pirro, M1
Patsourakos, NG1
Kouvari, M1
Kotidis, A1
Kalantzi, KI1
Tsoumani, ME1
Anastasiadis, F1
Andronikos, P1
Aslanidou, T1
Efraimidis, P1
Georgiopoulos, A1
Gerakiou, K1
Grigoriadou-Skouta, E1
Grigoropoulos, P1
Hatzopoulos, D1
Kartalis, A1
Lyras, A1
Markatos, G1
Mikrogeorgiou, A1
Myroforou, I1
Orkopoulos, A1
Pavlidis, P1
Petras, C1
Riga, M1
Skouloudi, M1
Smyrnioudis, N1
Thomaidis, K1
Tsikouri, GE1
Tsikouris, EI1
Zisimos, K1
Vavoulis, P1
Vitali, MG1
Vitsas, G1
Vogiatzidis, C1
Chantanis, S1
Fousas, S1
Panagiotakos, DB1
Tselepis, AD1
Jungen, C1
Alken, FA1
Eickholt, C1
Scherschel, K1
Kuklik, P1
Klatt, N1
Schwarzl, J1
Moser, J1
Jularic, M1
Akbulak, RO1
Schaeffer, B1
Willems, S1
Meyer, C1
Nowak, JK1
Szczepanik, M1
Trypuć, M1
Pogorzelski, A1
Bobkowski, W1
Grytczuk, M1
Minarowska, A1
Wójciak, R1
Walkowiak, J1
Lu, Y1
Xi, J1
Li, C1
Chen, W2
Hu, X1
Zhang, F1
Wei, H1
Wang, Z1
Gurzu, S1
Jung, I1
Sugimura, H2
Stefan-van Staden, RI1
Yamada, H1
Natsume, H1
Iwashita, Y1
Szodorai, R1
Szederjesi, J1
Yari, D1
Ehsanbakhsh, Z1
Validad, MH1
Langroudi, FH1
Esfandiari, H1
Prager, A1
Hassanpour, K1
Kurup, SP1
Mets-Halgrimson, R1
Yoon, H1
Zeid, JL1
Mets, MB1
Rahmani, B1
Araujo-Castillo, RV1
Culquichicón, C1
Solis Condor, R1
Efendi, F1
Sebayang, SK1
Astutik, E1
Hadisuyatmana, S1
Has, EMM1
Kuswanto, H1
Foroutan, T1
Ahmadi, F1
Moayer, F1
Khalvati, S1
Lyu, Y1
Huang, J1
Yu, N1
Wen, Z1
Hou, H1
Zhao, T1
Gupta, A1
Khosla, N1
Govindasamy, V1
Saini, A1
Annapurna, K1
Dhakate, SR1
Akkaya, Ö1
Chandgude, AL1
Dömling, A1
Harnett, J1
Oakes, K1
Carè, J1
Leach, M1
Brown, D1
Cramer, H1
Pinder, TA1
Steel, A1
Anheyer, D1
Cantu, J1
Valle, J1
Flores, K1
Gonzalez, D1
Valdes, C1
Lopez, J1
Padilla, V1
Alcoutlabi, M1
Parsons, J1
Núñez, K1
Hamed, M1
Fort, D1
Bruce, D1
Thevenot, P1
Cohen, A1
Weber, P1
Menezes, AMB1
Gonçalves, H1
Perez-Padilla, R1
Jarvis, D1
de Oliveira, PD1
Wehrmeister, FC1
Mir, S1
Wong, J1
Ryan, CM1
Bellingham, G1
Singh, M2
Waseem, R1
Eckert, DJ1
Chung, F1
Hegde, H1
Shimpi, N1
Panny, A1
Glurich, I1
Christie, P1
Acharya, A1
English, KL1
Downs, M1
Goetchius, E1
Buxton, R1
Ryder, JW1
Ploutz-Snyder, R1
Guilliams, M1
Scott, JM1
Ploutz-Snyder, LL1
Martens, C1
Goplen, FK1
Aasen, T1
Gjestad, R1
Nordfalk, KF1
Nordahl, SHG1
Inoue, T1
Soshi, S1
Kubota, M1
Marumo, K1
Mortensen, NP1
Caffaro, MM1
Patel, PR2
Uddin, MJ1
Aravamudhan, S1
Sumner, SJ1
Fennell, TR1
Gal, RL1
Cohen, NJ1
Kruger, D1
Beck, RW1
Bergenstal, RM1
Calhoun, P1
Cushman, T1
Haban, A1
Hood, K1
Johnson, ML1
McArthur, T1
Olson, BA1
Weinstock, RS1
Oser, SM1
Oser, TK1
Bugielski, B1
Strayer, H1
Aleppo, G1
Maruyama, H1
Hirayama, K1
Yamashita, M1
Ohgi, K1
Tsujimoto, R1
Takayasu, M1
Shimohata, H1
Kobayashi, M1
Buscagan, TM1
Rees, DC1
Jaborek, JR1
Zerby, HN1
Wick, MP1
Fluharty, FL1
Moeller, SJ1
Razavi, P1
Dickler, MN1
Shah, PD1
Toy, W1
Brown, DN1
Won, HH1
Li, BT1
Shen, R1
Vasan, N1
Modi, S1
Jhaveri, K1
Caravella, BA1
Patil, S1
Selenica, P1
Zamora, S1
Cowan, AM1
Comen, E1
Singh, A1
Covey, A1
Berger, MF1
Hudis, CA1
Norton, L1
Nagy, RJ1
Odegaard, JI1
Lanman, RB1
Solit, DB1
Robson, ME1
Lacouture, ME1
Brogi, E1
Reis-Filho, JS1
Moynahan, ME1
Scaltriti, M1
Chandarlapaty, S1
Papouskova, K1
Moravcova, M1
Masrati, G1
Ben-Tal, N1
Sychrova, H1
Zimmermannova, O1
Fang, J1
Fan, Y1
Luo, T2
Su, H1
Tsetseris, L1
Anthopoulos, TD1
Liu, SF1
Zhao, K1
Sacan, O1
Turkyilmaz, IB1
Bayrak, BB1
Mutlu, O1
Akev, N1
Yanardag, R1
Gruber, S1
Kamnoedboon, P1
Özcan, M1
Srinivasan, M1
Jo, YH1
Oh, HK1
Jeong, SY1
Lee, BG1
Zheng, J1
Guan, H1
Tan, H1
Maji, TK1
J R, A1
Mukherjee, S1
Alexander, R1
Mondal, A1
Das, S1
Sharma, RK1
Chakraborty, NK1
Dasgupta, K1
Sharma, AMR1
Hawaldar, R1
Pandey, M1
Naik, A1
Majumdar, K1
Pal, SK1
Adarsh, KV1
Ray, SK1
Karmakar, D1
Ma, Y2
Gao, W1
Ma, S1
Lin, W1
Zhou, T1
Wu, T1
Wu, Q1
Ye, C1
He, X1
Jiang, F1
Yuan, D1
Chen, Q1
Chen, K1
Hussain, M1
Razi, SS1
Yildiz, EA1
Zhao, J3
Yaglioglu, HG1
Donato, MD1
Jiang, J1
Jamil, MI1
Zhan, X1
Chen, F1
Cheng, D1
Wu, CT1
Utsunomiya, T1
Ichii, T1
Fujinami, S1
Nakajima, K1
Sanchez, DM1
Raucci, U1
Ferreras, KN1
Martínez, TJ1
Mordi, NA1
Mordi, IR1
Singh, JS1
McCrimmon, RJ1
Struthers, AD1
Lang, CC1
Wang, XW1
Yuan, LJ1
Chen, WF1
Luo, R1
Yang, K1
Amarasiri, SS1
Attanayake, AP1
Arawwawala, LDAM1
Jayatilaka, KAPW1
Mudduwa, LKB1
Ogunsuyi, O2
Akanni, O1
Alabi, O1
Alimba, C1
Adaramoye, O1
Cambier, S1
Eswara, S1
Gutleb, AC1
Bakare, A1
Gu, Z1
Cong, J1
Pellegrini, M1
Palmieri, S1
Ricci, A1
Serio, A1
Paparella, A1
Lo Sterzo, C1
Jadeja, SD1
Vaishnav, J1
Mansuri, MS1
Shah, C1
Mayatra, JM1
Shah, A1
Begum, R1
Song, H2
Lian, Y1
Wan, T1
Schultz-Lebahn, A1
Skipper, MT1
Hvas, AM1
Larsen, OH1
Hijazi, Z1
Granger, CB1
Hohnloser, SH1
Westerbergh, J1
Lindbäck, J1
Alexander, JH1
Keltai, M1
Parkhomenko, A1
López-Sendón, JL1
Lopes, RD1
Siegbahn, A1
Wallentin, L1
El-Tarabany, MS1
Saleh, AA1
El-Araby, IE1
El-Magd, MA1
van Ginkel, MPH1
Schijven, MP1
van Grevenstein, WMU1
Schreuder, HWR1
Pereira, EDM1
da Silva, J1
Carvalho, PDS1
Grivicich, I1
Picada, JN1
Salgado Júnior, IB1
Vasques, GJ1
Pereira, MADS1
Reginatto, FH1
Ferraz, ABF1
Vasilenko, EA1
Gorshkova, EN1
Astrakhantseva, IV1
Drutskaya, MS1
Tillib, SV1
Nedospasov, SA1
Mokhonov, VV1
Nam, YW1
Cui, M1
Orfali, R1
Viegas, A1
Nguyen, M1
Mohammed, EHM1
Zoghebi, KA1
Rahighi, S1
Parang, K1
Patterson, KC1
Kahanovitch, U1
Gonçalves, CM1
Hablitz, JJ1
Staruschenko, A1
Mulkey, DK1
Olsen, ML1
Gu, L1
Cao, X1
Mukhtar, A1
Wu, K1
Zhang, YY1
Zhu, Y1
Lu, DZ1
Dong, W1
Bi, WJ1
Feng, XJ1
Wen, LM1
Sun, H1
Qi, MC1
Chang, CC1
Dinh, TK1
Lee, YA1
Wang, FN1
Sung, YC1
Yu, PL1
Chiu, SC1
Shih, YC1
Wu, CY1
Huang, YD1
Lu, TT1
Wan, D1
Sakizadeh, J1
Cline, JP1
Snyder, MA1
Kiely, CJ1
McIntosh, S1
Jiang, X1
Cao, JW1
Zhao, CK1
Yang, R1
Zhang, QY1
Chen, KJ2
Liu, H3
He, Z1
Chen, B1
Wu, J1
Du, X2
Moore, J1
Blank, BR1
Eksterowicz, J1
Sutimantanapi, D1
Yuen, N1
Metzger, T1
Chan, B1
Huang, T2
Chen, X2
Duong, F1
Kong, W1
Chang, JH1
Sun, J1
Zavorotinskaya, T1
Ye, Q1
Junttila, MR1
Ndubaku, C1
Friedman, LS1
Fantin, VR1
Sun, D1
Fei, P1
Xie, Q1
Jiang, Y1
Feng, H1
Chang, Y1
Kang, H1
Xing, M1
Chen, J1
Shao, Z1
Yuan, C1
Allan, R1
Canham, K1
Wallace, R1
Singh, D1
Ward, J1
Cooper, A1
Newcomb, C1
Nammour, S1
El Mobadder, M1
Maalouf, E1
Namour, M1
Namour, A1
Rey, G1
Matamba, P1
Matys, J1
Zeinoun, T1
Grzech-Leśniak, K1
Segabinazi Peserico, C1
Garozi, L1
Zagatto, AM1
Machado, FA1
Hirth, JM1
Dinehart, EE1
Lin, YL1
Kuo, YF1
Nouri, SS1
Ritchie, C1
Volow, A1
Li, B2
McSpadden, S1
Dearman, K1
Kotwal, A1
Sudore, RL1
Ward, L1
Thakur, A1
Kondadasula, SV1
Ji, K1
Schalk, DL1
Bliemeister, E1
Ung, J1
Aboukameel, A1
Casarez, E1
Sloane, BF1
Lum, LG1
Xiao, M1
Gao, R1
Du, B1
Brooks, T1
Zwirner, J1
Hammer, N1
Ondruschka, B1
Jermy, M1
Luengo, A1
Marzo, I1
Reback, M1
Daubit, IM1
Fernández-Moreira, V1
Metzler-Nolte, N1
Gimeno, MC1
Tonchev, I1
Heberman, D1
Peretz, A1
Medvedovsky, AT1
Gotsman, I1
Rashi, Y1
Poles, L1
Goland, S1
Perlman, GY1
Danenberg, HD1
Beeri, R1
Shuvy, M1
Fu, Q1
Yang, D1
Sarapulova, A1
Pang, Q1
Meng, Y1
Wei, L1
Ehrenberg, H1
Kim, CC1
Jeong, SH1
Oh, KH1
Nam, KT1
Sun, JY1
Ning, J1
Duan, Z1
Kershaw, SV1
Rogach, AL1
Gao, Z1
Wang, T1
Li, Q1
Cao, T1
Guo, L1
Fu, Y1
Seeger, ZL1
Izgorodina, EI1
Hue, S1
Beldi-Ferchiou, A1
Bendib, I1
Surenaud, M1
Fourati, S1
Frapard, T1
Rivoal, S1
Razazi, K1
Carteaux, G1
Delfau-Larue, MH1
Mekontso-Dessap, A1
Audureau, E1
de Prost, N1
Gao, SS1
Duangthip, D1
Lo, ECM1
Chu, CH1
Roberts, W1
Rosenheck, RA1
Miyake, T1
Kimoto, E1
Luo, L1
Mathialagan, S1
Horlbogen, LM1
Ramanathan, R1
Wood, LS1
Johnson, JG1
Le, VH1
Vourvahis, M1
Rodrigues, AD1
Muto, C1
Furihata, K1
Sugiyama, Y1
Kusuhara, H1
Gong, Q1
Song, W1
Sun, B1
Cao, P1
Gu, S1
Sun, X1
Zhou, G1
Toma, C1
Khandhar, S1
Zalewski, AM1
D'Auria, SJ1
Tu, TM1
Jaber, WA1
Cho, J2
Suwandaratne, NS1
Razek, S1
Choi, YH1
Piper, LFJ1
Watson, DF1
Banerjee, S1
Xie, S1
Lindsay, AP1
Bates, FS1
Lodge, TP1
Hao, Y1
Chapovetsky, A1
Liu, JJ1
Welborn, M1
Luna, JM1
Do, T1
Haiges, R1
Miller Iii, TF1
Marinescu, SC1
Lopez, SA1
Compter, I1
Eekers, DBP1
Hoeben, A1
Rouschop, KMA1
Reymen, B1
Ackermans, L1
Beckervordersantforth, J1
Bauer, NJC1
Anten, MM1
Wesseling, P1
Postma, AA1
De Ruysscher, D1
Lambin, P1
Qiang, L1
Yang, S1
Cui, YH1
He, YY1
Kumar, SK1
Jacobus, SJ1
Cohen, AD1
Weiss, M1
Callander, N1
Singh, AK1
Parker, TL1
Menter, A1
Parsons, B1
Kumar, P1
Kapoor, P1
Rosenberg, A1
Zonder, JA1
Faber, E1
Lonial, S1
Anderson, KC1
Richardson, PG1
Orlowski, RZ1
Wagner, LI1
Rajkumar, SV1
Li, G3
Hou, G1
Cui, J1
Xie, H1
Sun, Z1
Fang, Z1
Dunstand-Guzmán, E1
Hallal-Calleros, C1
Hernández-Velázquez, VM1
Canales-Vargas, EJ1
Domínguez-Roldan, R1
Pedernera, M1
Peña-Chora, G1
Flores-Pérez, I1
Kim, MJ1
Han, C1
White, K1
Park, HJ1
Ding, D1
Boyd, K1
Rothenberger, C1
Bose, U1
Carmichael, P1
Linser, PJ1
Tanokura, M1
Salvi, R1
Someya, S1
Samuni, A1
Goldstein, S1
Divya, KP1
Dharuman, V1
Feng, J2
Qian, Y1
Cheng, Q1
Ma, H1
Ren, X1
Wei, Q1
Pan, W1
Guo, J1
Situ, B1
An, T1
Zheng, L1
Augusto, S1
Ratola, N1
Tarín-Carrasco, P1
Jiménez-Guerrero, P1
Turco, M1
Schuhmacher, M1
Costa, S1
Teixeira, JP1
Costa, C1
Syed, A1
Marraiki, N1
Al-Rashed, S1
Elgorban, AM1
Yassin, MT1
Chankhanittha, T1
Nanan, S1
Sorokina, KN1
Samoylova, YV1
Gromov, NV1
Ogorodnikova, OL1
Parmon, VN1
Ye, J1
Liao, W1
Zhang, P1
Nabi, M1
Cai, Y1
Li, F1
Alsbou, EM1
Omari, KW1
Adeosun, WA1
Asiri, AM1
Marwani, HM1
Barral, M1
Jemal-Turki, A1
Beuvon, F1
Soyer, P1
Camparo, P1
Cornud, F1
Atwater, BD1
Jones, WS1
Loring, Z1
Friedman, DJ1
Namburath, M1
Papirio, S1
Moscariello, C1
Di Costanzo, N1
Pirozzi, F1
Alappat, BJ1
Sreekrishnan, TR1
Volpin, F1
Woo, YC1
Kim, H1
Freguia, S1
Jeong, N1
Choi, JS1
Phuntsho, S1
Shon, HK1
Domínguez-Zambrano, E1
Pedraza-Chaverri, J1
López-Santos, AL1
Medina-Campos, ON1
Cruz-Rivera, C1
Bueno-Hernández, F1
Espinosa-Cuevas, A1
Bulavaitė, A1
Dalgediene, I1
Michailoviene, V1
Pleckaityte, M1
Sauerbier, P1
Köhler, R1
Renner, G1
Militz, H1
Wang, D2
Sun, L1
Zhang, G1
Liang, Z1
Yin, S1
Su, M1
Liang, D1
Correa, S1
Curtis, KA1
Waikar, SS1
Mc Causland, FR1
Seki, H1
Kaneko, H1
Morita, H1
Itoh, H1
Morita, K1
Matsuoka, S1
Kiriyama, H1
Kamon, T1
Fujiu, K1
Michihata, N1
Jo, T1
Takeda, N1
Yano, Y1
Nakamura, S1
Node, K1
Yasunaga, H1
Komuro, I1
Vrachatis, DA1
Papathanasiou, KA1
Iliodromitis, KE1
Giotaki, SG1
Kossyvakis, C1
Raisakis, K1
Kaoukis, A1
Lambadiari, V1
Avramides, D1
Reimers, B1
Stefanini, GG1
Cleman, M1
Giannopoulos, G1
Lansky, A1
Deftereos, SG1
Zhou, J1
Ren, M1
Zhou, XH1
Ruozha, B1
Song, SF1
Li, YD1
Zhang, JH1
Xing, Q1
Lu, YM1
Tang, BP1
Chen, YJ1
Huang, WM1
Wu, CL1
Huang, CJ1
Hsu, PF2
Yeh, JS1
Yu, WC1
Chen, CH1
Mantovani, A2
Rigolon, R2
Civettini, A1
Bolzan, B1
Morani, G1
Bonapace, S2
Dugo, C1
Zoppini, G3
Bonora, E2
Targher, G3
Manolis, AJ1
Castro-Torres, Y1
Khan, NY1
Carmona-Puerta, R1
Han, X1
Yin, X1
Zhou, Y1
Pak, S1
Yatsynovich, Y1
Valencia, D1
Chen, T1
Black-Maier, E1
Daubert, JP1
Miao, M1
Pan, Y1
Xu, L2
Zhu, Z1
Xu, RH1
Xu, JB1
Liu, ZH1
Zhang, TJ1
Kwon, CH1
Lee, SH1
Lee, JY1
Ryu, S1
Sung, KC1
Kawasoe, S2
Kubozono, T2
Yoshifuku, S2
Ojima, S2
Miyata, M2
Miyahara, H2
Maenohara, S2
Ohishi, M2
Kuwabara, M3
Hisatome, I3
Shibata, Y1
Inoue, S1
Watanabe, M1
Ono, K1
Masi, S1
Pugliese, NR1
Taddei, S1
Cui, L1
Gurol, ME1
Bhatt, DL1
Fonarow, GC1
Benjamin, EJ1
Xing, A2
Wu, S2
Gao, X1
He, XN1
Li, SN1
Zhan, JL1
Xie, SL1
Zhang, ZJ1
Dong, JZ2
Yu, RH2
Long, DY2
Tang, RB2
Ma, CS2
Valbusa, F1
Bertolini, L1
Zenari, L1
Arcaro, G1
Byrne, CD1
Koza, Y2
Simsek, Z1
Tas, MH1
Chao, TF1
Hung, CL1
Chen, SJ1
Wang, KL1
Chen, TJ1
Lin, YJ1
Chang, SL1
Lo, LW1
Hu, YF2
Tuan, TC1
Chen, SA2
Nyrnes, A1
Toft, I1
Njølstad, I1
Mathiesen, EB1
Wilsgaard, T1
Hansen, JB1
Løchen, ML1
Tekin, G2
Tekin, YK2
Wan, YF1
Zheng, YL1
Niu, HY1
Xu, CQ1
He, YQ1
Chen, JH1
Zheng, DH1
Su, HM1
Lin, TH1
Hsu, PC1
Lee, WH1
Chu, CY1
Lee, CS1
Yen, HW1
Lai, WT1
Sheu, SH1
Voon, WC1
Tamariz, L2
Hernandez, F1
Bush, A1
Palacio, A1
Hare, JM1
Numa, S1
Hirai, T1
Nakagawa, K1
Ohara, K1
Fukuda, N1
Nozawa, T1
Inoue, H1
Chuang, SY1
Wu, CC1
Chia-Yu Chen, R1
Liu, WL1
Hsu, YY1
Pan, WH1
Canpolat, U1
Aytemir, K1
Yorgun, H1
Şahiner, L1
Kaya, EB1
Çay, S1
Topaloğlu, S1
Aras, D1
Oto, A1
Nattel, S1
Yan, XL1
Kang, JP1
Wu, JH1
Ning, M1
Sang, CH1
Jiang, CX1
Salim, M1
Bai, R1
Celik, M1
Yalcinkaya, E1
Yuksel, UC1
Gokoglan, Y1
Bugan, B1
Kabul, HK1
Barcin, C1
Ding, X1
Zheng, X1
Qi, S1
Hong, J1
Memetoglu, ME1
Kehlibar, T1
Yılmaz, M1
Günay, R1
Arslan, Y1
Tuygun, A1
Kocaaslan, C1
Çoskun, G1
Ketenci, B1
Güney, MR1
Demirtas, M1
Katsiki, N1
Mikhailidis, DP1
Pichiri, I1
Pernigo, M1
Bergamini, C1
Shi, D1
Meng, Q1
Li, L1
Liu, K1
He, S1
Liu, T2
Korantzopoulos, P2
Letsas, KP1
Zhang, Z1
Çanga, Y1
İpek, G1
Özcan, KS1
Güngör, B1
Onuk, T1
Öz, A1
Şimşek, B1
Bolca, O1
Krittayaphong, R1
Rangsin, R1
Thinkhamrop, B1
Hurst, C1
Rattanamongkolgul, S1
Sripaiboonkij, N1
Yindeengam, A1
Zhang, CH1
Huang, DS1
Shen, D1
Zhang, LW1
Ma, YJ1
Wang, YM1
Sun, HY1
Liang, WY1
Liu, WW1
Liu, ML1
Feng, XR1
Huang, B1
Chen, XH1
Sun, YS1
Maharani, N1
Çakar, M1
Metin, S1
Balta, Ş1
Öztürk, C1
Demirkol, S1
Çakmak, T1
İnal, S1
Çelik, T1
İyisoy, A1
Ünlü, M1
Şen, A1
Shi, JH1
Xing, AJ1
Wang, YZ1
Ji, CP1
Zhu, CR1
Wei, XM1
Wu, SL1
Oketani, N1
Niwa, K1
Nishihara, S1
Nishi, Y1
Takahashi, O1
Kario, K1
Yamashita, T2
Li, N1
Dobrev, D1
Yeh, HI1
Agarwal, S1
Soliman, EZ1
Chamberlain, AM1
Prineas, R1
Folsom, AR1
Ambrose, M1
Alonso, A1
Suzuki, S1
Sagara, K1
Otsuka, T1
Matsuno, S1
Funada, R1
Uejima, T1
Oikawa, Y1
Koike, A1
Nagashima, K1
Kirigaya, H1
Yajima, J1
Sawada, H1
Aizawa, T1
Watanabe, E1
Erbay, AR1
Turhan, H1
Yetkin, E1
Zhao, QY1
Yu, SB1
Cui, HY1
Qin, M1
Huang, CX1
Kapoor, S1
Chrysant, SG1
Chrysant, GS1
Gambina, G1
Corso, L1
Deotto, L1
Tarondi, GL1
Brighenti, M1
Ciccarelli, C1
Preite, G1
Zardini, GB1
Montanari, M1
Sbarbaro, V1
Steele, P1
Rainwater, J1
Barriales Alvarez, V1
Rodríguez Blanco, VM1
Barriales Villa, R1
Möller Bustinza, I1
Batalla Celorio, A1
Castellanos Martínez, E1
Moris de la Tassa, C1
Mayordomo López, J1
Gautier, JC1
Morelot, D1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Secretoneurin as a Biomarker of Atrial Fibrillation rEcurrence After Catheter Ablation/Electrical Cardioversion[NCT05794464]60 participants (Anticipated)Interventional2023-05-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

10 reviews available for uric acid and Auricular Fibrillation

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations.
    Drugs, 2021, Volume: 81, Issue:12

    Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Remodeling; Diabetes Mellitus, Type 2; Energy Me

2021
Relationship between serum uric acid levels and different types of atrial fibrillation: An updated meta-analysis.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2021, 09-22, Volume: 31, Issue:10

    Topics: Adult; Aged; Atrial Fibrillation; Biomarkers; Female; Heart Rate; Humans; Hyperuricemia; Incidence;

2021
Serum Uric Acid and Atrial Fibrillation: Meta-analysis.
    Critical pathways in cardiology, 2018, Volume: 17, Issue:3

    Topics: Atrial Fibrillation; Humans; Risk Factors; Uric Acid

2018
Impact of reduced pulmonary function in the Japanese general population: Lessons from the Yamagata-Takahata study.
    Respiratory investigation, 2019, Volume: 57, Issue:3

    Topics: Adiponectin; Asian People; Atrial Fibrillation; Biomarkers; Cigarette Smoking; Comorbidity; Diabetes

2019
Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis.
    Heart rhythm, 2014, Volume: 11, Issue:7

    Topics: Atrial Fibrillation; Biomarkers; Humans; Oxidative Stress; Risk Factors; Uric Acid

2014
Association between serum uric acid and atrial fibrillation recurrence following catheter ablation: A meta-analysis.
    International journal of cardiology, 2016, Feb-01, Volume: 204

    Topics: Atrial Fibrillation; Biomarkers; Catheter Ablation; Cohort Studies; Humans; Postoperative Complicati

2016
Association Between Serum Uric Acid Levels and Atrial Fibrillation Risk.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 38, Issue:4

    Topics: Atrial Fibrillation; Databases, Factual; Humans; Hyperuricemia; Risk Factors; Uric Acid

2016
Hyperuricemia and Atrial Fibrillation.
    International heart journal, 2016, Jul-27, Volume: 57, Issue:4

    Topics: Antioxidants; Atrial Fibrillation; Atrial Remodeling; Evidence-Based Medicine; Humans; Hyperuricemia

2016
The pleiotropic effects of angiotensin receptor blockers.
    Journal of clinical hypertension (Greenwich, Conn.), 2006, Volume: 8, Issue:4

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting En

2006

Trials

8 trials available for uric acid and Auricular Fibrillation

ArticleYear
Declines in serum uric acid level after catheter ablation of atrial fibrillation.
    Heart and vessels, 2022, Volume: 37, Issue:12

    Topics: Aged; Atrial Fibrillation; Biomarkers; Catheter Ablation; Female; Glucose; Humans; Lipids; Male; Mid

2022
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Uric Acid and Risk of Atrial Fibrillation in the Korean General Population.
    Circulation journal : official journal of the Japanese Circulation Society, 2018, 10-25, Volume: 82, Issue:11

    Topics: Adult; Atrial Fibrillation; C-Reactive Protein; Electrocardiography; Female; Follow-Up Studies; Huma

2018
Uric Acid Level and New-Onset Atrial Fibrillation in the Japanese General Population　- Longitudinal Study.
    Circulation journal : official journal of the Japanese Circulation Society, 2018, 12-25, Volume: 83, Issue:1

    Topics: Adult; Age Factors; Aged; Asian People; Atrial Fibrillation; Female; Humans; Japan; Longitudinal Stu

2018
The association between hyperuricemia, left atrial size and new-onset atrial fibrillation.
    International journal of cardiology, 2013, Oct-09, Volume: 168, Issue:4

    Topics: Adult; Atrial Fibrillation; Biomarkers; Cohort Studies; Female; Heart Atria; Humans; Hyperuricemia;

2013
Hyperuricemia and transesophageal echocardiographic thromboembolic risk in patients with atrial fibrillation at clinically low-intermediate risk.
    Circulation journal : official journal of the Japanese Circulation Society, 2014, Volume: 78, Issue:7

    Topics: Adult; Aged; Atrial Fibrillation; Echocardiography, Transesophageal; Female; Humans; Hyperuricemia;

2014
Uric Acid Level and Prevalence of Atrial Fibrillation in a Japanese General Population of 285,882.
    Circulation journal : official journal of the Japanese Circulation Society, 2016, Nov-25, Volume: 80, Issue:12

    Topics: Adult; Age Factors; Aged; Asian People; Atrial Fibrillation; Body Mass Index; Female; Glomerular Fil

2016
Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects.
    Circulation, 1972, Volume: 45, Issue:5

    Topics: Adult; Age Factors; Aged; Aneurysm; Atrial Fibrillation; Blood Glucose; Blood Pressure; Cerebrovascu

1972

Other Studies

73 other studies available for uric acid and Auricular Fibrillation

ArticleYear
A Prediction Rule Including Interleukin-6 in Pericardial Drainage Improves Prediction of New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting.
    Journal of cardiothoracic and vascular anesthesia, 2022, Volume: 36, Issue:7

    Topics: Atrial Fibrillation; Coronary Artery Bypass; Drainage; Humans; Interleukin-6; Postoperative Complica

2022
Combined Effect of Homocysteine and Uric Acid to Identify Patients With High Risk for Subclinical Atrial Fibrillation.
    Journal of the American Heart Association, 2022, 01-04, Volume: 11, Issue:1

    Topics: Atrial Fibrillation; Female; Homocysteine; Humans; Male; Pacemaker, Artificial; Risk Factors; Uric A

2022
Correlation between Left Atrial Thrombosis and Neutrophil-to-Lymphocyte Ratio upon Non-Valvular Atrial Fibrillation.
    Clinical laboratory, 2022, Feb-01, Volume: 68, Issue:2

    Topics: Atrial Fibrillation; Humans; Lymphocytes; Neutrophils; Retrospective Studies; Risk Assessment; Throm

2022
Serum Uric Acid Levels in Relation to Atrial Fibrillation: A Case-Control Study.
    Medical science monitor : international medical journal of experimental and clinical research, 2022, 02-27, Volume: 28

    Topics: Atrial Fibrillation; Biomarkers; Case-Control Studies; Female; Humans; Male; Middle Aged; Risk Facto

2022
The Impact of Serum Uric Acid on Postoperative Atrial Fibrillation in Coronary Artery Bypass Graft.
    The heart surgery forum, 2022, Apr-29, Volume: 25, Issue:2

    Topics: Atrial Fibrillation; Coronary Artery Bypass; Female; Humans; Male; Postoperative Complications; Retr

2022
Retrospective Study from a Single Center to Evaluate the Association Between Sex and Serum Uric Acid Levels in 950 Patients with Atrial Fibrillation.
    Medical science monitor : international medical journal of experimental and clinical research, 2022, May-12, Volume: 28

    Topics: Atrial Fibrillation; Female; Humans; Male; Regression Analysis; Retrospective Studies; Risk Factors;

2022
A case-control study to investigate association between serum uric acid levels and paroxysmal atrial fibrillation.
    Scientific reports, 2022, 06-20, Volume: 12, Issue:1

    Topics: Atrial Fibrillation; Case-Control Studies; Cholesterol, HDL; Female; Humans; Risk Factors; Uric Acid

2022
Association of Hyperuricemia with Impaired Left Ventricular Systolic Function in Patients with Atrial Fibrillation and Preserved Kidney Function: Analysis of the POL-AF Registry Cohort.
    International journal of environmental research and public health, 2022, 06-14, Volume: 19, Issue:12

    Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Diuretics; Humans; Hyperuricemia; Kidney; Middle Aged;

2022
Predictive value of uric acid/albumin ratio for the prediction of new-onset atrial fibrillation in patients with ST-Elevation myocardial infarction.
    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 2022, May-02, Volume: 74, Issue:3

    Topics: Atrial Fibrillation; C-Reactive Protein; Cross-Sectional Studies; Humans; Retrospective Studies; Ris

2022
Association of Uric Acid Albumin Ratio with Recurrence of Atrial Fibrillation after Cryoballoon Catheter Ablation.
    Medicina (Kaunas, Lithuania), 2022, Dec-19, Volume: 58, Issue:12

    Topics: Atrial Fibrillation; Catheter Ablation; Humans; Recurrence; Risk Factors; Treatment Outcome; Uric Ac

2022
Elevated Uric Acid Is Associated With New-Onset Atrial Fibrillation: Results From the Swedish AMORIS Cohort.
    Journal of the American Heart Association, 2023, 02-07, Volume: 12, Issue:3

    Topics: Atrial Fibrillation; Humans; Incidence; Risk Factors; Sweden; Uric Acid

2023
Association between serum uric acid levels and atrial fibrillation in different fasting glucose patterns: A case-control study.
    Frontiers in endocrinology, 2023, Volume: 14

    Topics: Apolipoproteins B; Atrial Fibrillation; Case-Control Studies; Fasting; Glucose; Humans; Risk Factors

2023
Uric acid significantly correlates with the presence of low-voltage areas at the endocardial mapping in patients with non-valvular atrial fibrillation.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2023, Volume: 33, Issue:7

    Topics: Atrial Fibrillation; Cross-Sectional Studies; Fibrosis; Heart Atria; Humans; Uric Acid

2023
Serum uric acid: creatinine ratio (UCR) is associated with recurrence of atrial fibrillation after catheter ablation.
    Frontiers in endocrinology, 2023, Volume: 14

    Topics: Atrial Fibrillation; Catheter Ablation; Creatinine; Humans; Male; Risk Factors; Treatment Outcome; U

2023
Association between paroxysmal or persistent atrial fibrillation and hyperuricemia in patients who underwent coronary computed tomography angiography: from the FU-CCTA-AF Registry.
    Heart and vessels, 2023, Volume: 38, Issue:12

    Topics: Atrial Fibrillation; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease;

2023
Incorporating uric acid into the CHA2DS2-VASc score improves the prediction of new-onset atrial fibrillation in patients with acute myocardial infarction.
    BMC cardiovascular disorders, 2023, 10-27, Volume: 23, Issue:1

    Topics: Atrial Fibrillation; Humans; Myocardial Infarction; Predictive Value of Tests; Retrospective Studies

2023
Predictive value of echocardiography combined with CT angiography for left atrial appendage thrombosis in patients with non-valvular atrial fibrillation.
    European review for medical and pharmacological sciences, 2023, Volume: 27, Issue:21

    Topics: Atrial Appendage; Atrial Fibrillation; Computed Tomography Angiography; Echocardiography, Transesoph

2023
Prognostic Value of Serum Uric Acid in Hospitalized Heart Failure Patients With Preserved Ejection Fraction (from the Japanese Nationwide Multicenter Registry).
    The American journal of cardiology, 2020, 03-01, Volume: 125, Issue:5

    Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-

2020
A mendelian randomization analysis: The causal association between serum uric acid and atrial fibrillation.
    European journal of clinical investigation, 2020, Volume: 50, Issue:10

    Topics: Adult; Atrial Fibrillation; Causality; Female; Humans; Hyperuricemia; Male; Mendelian Randomization

2020
A statistical predictive model consistent within a 5-year follow-up period for patients with acute heart failure.
    Journal of the Chinese Medical Association : JCMA, 2020, Volume: 83, Issue:11

    Topics: Acute Disease; Aged; Atrial Fibrillation; Diabetes Complications; Female; Follow-Up Studies; Heart F

2020
Increased Susceptibility of Atrial Fibrillation Induced by Hyperuricemia in Rats: Mechanisms and Implications.
    Cardiovascular toxicology, 2021, Volume: 21, Issue:3

    Topics: Actins; Animals; Apoptosis; Atrial Fibrillation; Atrial Remodeling; bcl-2-Associated X Protein; Benz

2021
Serum Myeloperoxidase, Uric Acid, and the Risk of Atrial Fibrillation in Chronic Kidney Disease.
    Circulation. Arrhythmia and electrophysiology, 2021, Volume: 14, Issue:4

    Topics: Adult; Aged; Atrial Fibrillation; Female; Humans; Incidence; Male; Middle Aged; Peroxidase; Renal In

2021
Relation of Serum Uric Acid and Cardiovascular Events in Young Adults Aged 20-49 Years.
    The American journal of cardiology, 2021, 08-01, Volume: 152

    Topics: Adult; Atrial Fibrillation; Cardiovascular Diseases; Female; Heart Failure; Humans; Hyperuricemia; I

2021
[The relationship between LDL-C and ischemic stroke in 2 470 patients with nonvalvular atrial fibrillation in Xinjiang region].
    Zhonghua nei ke za zhi, 2017, Apr-01, Volume: 56, Issue:4

    Topics: Aged; Atrial Fibrillation; Case-Control Studies; Cholesterol; Cholesterol, LDL; Female; Humans; Male

2017
Performance of AHEAD Score in an Asian Cohort of Acute Heart Failure With Either Preserved or Reduced Left Ventricular Systolic Function.
    Journal of the American Heart Association, 2017, May-04, Volume: 6, Issue:5

    Topics: Acute Disease; Aged; Aged, 80 and over; Asian People; Atrial Fibrillation; Biomarkers; Cardiovascula

2017
Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring.
    Journal of endocrinological investigation, 2018, Volume: 41, Issue:2

    Topics: Aged; Atrial Fibrillation; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Humans; Hyper

2018
Serum uric acid and atrial fibrillation.
    Current medical research and opinion, 2017, Volume: 33, Issue:sup3

    Topics: Atrial Fibrillation; Humans; Prevalence; Risk Factors; Uric Acid

2017
Levels of uric acid and increased diastolic blood pressure: Risk factors for atrial fibrillation in patients older than 60 years.
    Revista da Associacao Medica Brasileira (1992), 2017, Volume: 63, Issue:7

    Topics: Aged; Atrial Fibrillation; Blood Pressure; Cardiovascular Diseases; Electrocardiography; Female; Hum

2017
Association between serum uric acid and atrial fibrillation: a cross-sectional community-based study in China.
    BMJ open, 2017, 12-22, Volume: 7, Issue:12

    Topics: Adult; Atrial Fibrillation; China; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Logistic

2017
Editorial Commentary: Prevention and treatment of atrial fibrillation: Is hyperuricemia the next target?
    Trends in cardiovascular medicine, 2019, Volume: 29, Issue:1

    Topics: Atrial Fibrillation; Gout; Humans; Hyperuricemia; Uric Acid

2019
Nonalcoholic Fatty Liver Disease Is Associated with Increased Atrial Fibrillation Risk in an Elderly Chinese Population: A Cross-Sectional Study.
    BioMed research international, 2018, Volume: 2018

    Topics: Adult; Aged; Atrial Fibrillation; China; Cross-Sectional Studies; Female; Humans; Male; Non-alcoholi

2018
Hyperuricemia is associated with atrial fibrillation prevalence in very elderly - a community based study in Chengdu, China.
    Scientific reports, 2018, 08-17, Volume: 8, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Atrial Fibrillation; China; Comorbidity; Female; Humans; Hyper

2018
Gender Difference in the Association Between Uric Acid and Atrial Fibrillation.
    Circulation journal : official journal of the Japanese Circulation Society, 2018, 12-25, Volume: 83, Issue:1

    Topics: Atrial Fibrillation; Humans; Japan; Longitudinal Studies; Sex Factors; Uric Acid

2018
How Is Uric Acid Related to Atrial Fibrillation?
    Circulation journal : official journal of the Japanese Circulation Society, 2019, 03-25, Volume: 83, Issue:4

    Topics: Atrial Fibrillation; Humans; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Risk Factors; Uric Ac

2019
The difficult relationship between uric acid and cardiovascular disease.
    European heart journal, 2019, 09-21, Volume: 40, Issue:36

    Topics: Aged; Allopurinol; Atrial Fibrillation; Cardiovascular Diseases; Febuxostat; Humans; Medicare; Risk

2019
Cohort Study of Repeated Measurements of Serum Urate and Risk of Incident Atrial Fibrillation.
    Journal of the American Heart Association, 2019, 07-02, Volume: 8, Issue:13

    Topics: Adult; Atrial Fibrillation; C-Reactive Protein; China; Cohort Studies; Electrocardiography; Female;

2019
Serum uric acid levels correlate with recurrence of paroxysmal atrial fibrillation after catheter ablation.
    Chinese medical journal, 2013, Volume: 126, Issue:5

    Topics: Aged; Atrial Fibrillation; Catheter Ablation; Electrophysiology; Female; Humans; Male; Middle Aged;

2013
Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus.
    The American journal of cardiology, 2013, Aug-15, Volume: 112, Issue:4

    Topics: Aged; Atrial Fibrillation; Biomarkers; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type

2013
Uric acid levels and atrial fibrillation.
    Angiology, 2014, Volume: 65, Issue:2

    Topics: Atrial Fibrillation; Female; Heart Failure; Humans; Male; Myocardial Ischemia; Uric Acid

2014
Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women--the Tromso Study.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2014, Volume: 16, Issue:3

    Topics: Age Distribution; Aged; Aged, 80 and over; Atrial Fibrillation; Biomarkers; Female; Follow-Up Studie

2014
Response to the letter: uric acid levels and atrial fibrillation.
    Angiology, 2014, Volume: 65, Issue:2

    Topics: Atrial Fibrillation; Female; Heart Failure; Humans; Male; Myocardial Ischemia; Uric Acid

2014
Uric acid levels in obstructive sleep apnea patients with atrial fibrillation.
    Archives of medical research, 2014, Volume: 45, Issue:2

    Topics: Adult; Aged; Atrial Fibrillation; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate A

2014
Association of hyperuricemia with cardiac events in patients with atrial fibrillation.
    International journal of cardiology, 2014, Mar-15, Volume: 172, Issue:2

    Topics: Aged; Atrial Fibrillation; Biomarkers; Cause of Death; Female; Glomerular Filtration Rate; Hospitali

2014
Uric acid elevation in atrial fibrillation: is it simply an epiphenomenon or not?
    International journal of cardiology, 2014, Jul-01, Volume: 174, Issue:3

    Topics: Atrial Fibrillation; Biomarkers; Heart Failure; Humans; Uric Acid

2014
Hyperuricemia and incident atrial fibrillation in a normotensive elderly population in Taiwan.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2014, Volume: 24, Issue:9

    Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Blood Pressure; Electrocardiography; Female; Follow-Up

2014
Usefulness of serum uric acid level to predict atrial fibrillation recurrence after cryoballoon-based catheter ablation.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2014, Volume: 16, Issue:12

    Topics: Atrial Fibrillation; Biomarkers; Cardiac Catheterization; Cryosurgery; Female; Humans; Male; Middle

2014
Serum uric acid concentration and left atrial thrombus: biomarker, pathophysiological indicator, or innocent bystander?
    The Canadian journal of cardiology, 2014, Volume: 30, Issue:11

    Topics: Atrial Fibrillation; Catheter Ablation; Female; Heart Atria; Heart Diseases; Humans; Male; Thrombosi

2014
Serum uric acid and risk of left atrial thrombus in patients with nonvalvular atrial fibrillation.
    The Canadian journal of cardiology, 2014, Volume: 30, Issue:11

    Topics: Atrial Fibrillation; Biomarkers; Catheter Ablation; China; Echocardiography, Transesophageal; Female

2014
Increased serum uric acid levels are correlated with decreased left atrial appendage peak flow velocity in patients with atrial fibrillation.
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2015, Volume: 24, Issue:3

    Topics: Age Factors; Aged; Atrial Appendage; Atrial Fibrillation; Blood Flow Velocity; Comorbidity; Echocard

2015
High risk factors of atrial fibrillation in type 2 diabetes: results from the Chinese Kailuan study.
    QJM : monthly journal of the Association of Physicians, 2015, Volume: 108, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; China; Diabetes Mellitus, Type 2; Diabetic Angi

2015
Serum uric acid level predicts new-onset atrial fibrillation after coronary artery bypass graft operation.
    European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:5

    Topics: Adult; Aged; Atrial Fibrillation; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Postope

2015
Hyperuricaemia in cardiovascular diseases: a passive or an active player?
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2015, Volume: 24, Issue:3

    Topics: Atrial Appendage; Atrial Fibrillation; Female; Humans; Male; Uric Acid

2015
Hyperuricemia is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes.
    Journal of endocrinological investigation, 2016, Volume: 39, Issue:2

    Topics: Aged; Aged, 80 and over; Allopurinol; Atrial Fibrillation; Cross-Sectional Studies; Diabetes Mellitu

2016
Factors influencing the relationship between atrial fibrillation and artery stiffness in elderly Chinese patients with hypertension.
    Aging clinical and experimental research, 2016, Volume: 28, Issue:4

    Topics: Aged; Aged, 80 and over; Ankle Brachial Index; Arteries; Asian People; Atrial Fibrillation; Cross-Se

2016
Association of admission serum laboratory parameters with new-onset atrial fibrillation after a primary percutaneous coronary intervention.
    Coronary artery disease, 2016, Volume: 27, Issue:2

    Topics: Adult; Aged; Atrial Fibrillation; Blood Glucose; C-Reactive Protein; Creatinine; Erythrocyte Indices

2016
Prevalence and associating factors of atrial fibrillation in patients with hypertension: a nation-wide study.
    BMC cardiovascular disorders, 2016, Mar-22, Volume: 16

    Topics: Age Factors; Aged; Atrial Fibrillation; Biomarkers; Chi-Square Distribution; Cholesterol, LDL; Comor

2016
Serum uric acid level and left ventricular hypertrophy in elderly male patients with nonvalvular atrial fibrillation.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2016, Volume: 26, Issue:7

    Topics: Age Factors; Aged; Aged, 80 and over; Atrial Fibrillation; Biomarkers; Chi-Square Distribution; Huma

2016
Military jet pilots have higher p-wave dispersions compared to the transport aircraft aircrew.
    International journal of occupational medicine and environmental health, 2016, Volume: 29, Issue:4

    Topics: Adult; Aerospace Medicine; Atrial Fibrillation; Electrocardiography; Humans; Male; Military Personne

2016
[Association between the cardiovascular health score and new-onset atrial fibrillation].
    Zhonghua xin xue guan bing za zhi, 2016, Aug-24, Volume: 44, Issue:8

    Topics: Atrial Fibrillation; C-Reactive Protein; Humans; Incidence; Multivariate Analysis; Myocardial Infarc

2016
Hyperuricemia is an independent competing risk factor for atrial fibrillation.
    International journal of cardiology, 2017, Mar-15, Volume: 231

    Topics: Atrial Fibrillation; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Incidence; Male; Middle

2017
Hyperuricemia: A causal player or a bystander linking inflammatory signaling and atrial fibrillation?
    International journal of cardiology, 2017, Mar-15, Volume: 231

    Topics: Atrial Fibrillation; Humans; Hyperuricemia; Inflammasomes; NLR Family, Pyrin Domain-Containing 3 Pro

2017
Metabolic syndrome does not impose greater atrial fibrillation risk in elderly hypertensive patients.
    Acta cardiologica, 2010, Volume: 65, Issue:6

    Topics: Age Factors; Aged; Atrial Fibrillation; Creatinine; Diuretics; Female; Humans; Hypertension; Hypertr

2010
Uric acid levels and atrial fibrillation in hypertensive patients.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:8

    Topics: Adult; Aged; Atrial Fibrillation; Biomarkers; Creatinine; Cross-Sectional Studies; Echocardiography;

2011
Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study).
    The American journal of cardiology, 2011, Nov-01, Volume: 108, Issue:9

    Topics: Atrial Fibrillation; Black People; Female; Humans; Incidence; Longitudinal Studies; Male; Middle Age

2011
Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence.
    Circulation journal : official journal of the Japanese Circulation Society, 2012, Volume: 76, Issue:3

    Topics: Adult; Aged; Atrial Fibrillation; Cardiovascular Diseases; Cohort Studies; Female; Humans; Male; Mid

2012
Uric acid and atrial fibrillation - cause or other association? - .
    Circulation journal : official journal of the Japanese Circulation Society, 2012, Volume: 76, Issue:3

    Topics: Atrial Fibrillation; Female; Humans; Male; Uric Acid

2012
Serum uric acid levels are associated with atrial fibrillation in patients with ischemic heart failure.
    Angiology, 2013, Volume: 64, Issue:4

    Topics: Aged; Atrial Fibrillation; Biomarkers; Chronic Disease; Female; Heart Atria; Heart Failure; Humans;

2013
Serum uric acid levels correlate with atrial fibrillation in patients with chronic systolic heart failure.
    Chinese medical journal, 2012, Volume: 125, Issue:10

    Topics: Aged; Atrial Fibrillation; Female; Heart Failure, Systolic; Humans; Male; Middle Aged; Uric Acid

2012
Beyond atrial fibrillation and heart failure: the evolving role of uric acid in cardio- vascular pathologies and morbidity.
    Chinese medical journal, 2012, Volume: 125, Issue:20

    Topics: Atrial Fibrillation; Heart Failure; Humans; Morbidity; Uric Acid

2012
Reversible cerebral ischemias: a comparative analysis of risk factors in TIAs and in RINDs.
    Italian journal of neurological sciences, 1984, Volume: 5, Issue:2

    Topics: Atrial Fibrillation; Brain Ischemia; Female; Hematocrit; Humans; Hypercholesterolemia; Hypertension;

1984
Favorable effect of sulfinpyrazone on thromboembolism in patients with rheumatic heart disease.
    Circulation, 1980, Volume: 62, Issue:3

    Topics: Atrial Fibrillation; Blood Coagulation; Blood Platelets; Cell Survival; Heart Valve Prosthesis; Huma

1980
[Study of associated risk factors and prevalence of heart diseases in patients with arterial hypertension].
    Anales de medicina interna (Madrid, Spain : 1984), 1995, Volume: 12, Issue:6

    Topics: Aged; Alcohol Drinking; Atrial Fibrillation; Coronary Disease; Data Interpretation, Statistical; Dia

1995
[Cerebral infarctions. Study of their prevention].
    La Nouvelle presse medicale, 1975, Oct-25, Volume: 4, Issue:36

    Topics: Adult; Aged; Atrial Fibrillation; Contraceptive Agents; Diabetes Complications; Female; Heart Diseas

1975